FA
MEDP icon

Friess Associates’s Medpace MEDP Stock Holding History

Friess Associates’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-256,326
Closed -$9.25M – 144
2016
Q4 		$9.25M Sell
256,326
-14,054
-5% -$468K 0.91% 54
2016
Q3 		$8.07M Buy
+270,380
New +$7.9M 0.78% 58

Other funds holding MEDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return
BCA
Bernzott Capital Advisors Camarillo, California $250M AUM 26.89% 1-Year Est. Return

Friess Associates's MEDP Position: Q1 2017 in Review

Friess Associates sold out of Medpace (MEDP) in Q1 2017, closing a stake of 256,326 shares — an estimated $9.25M sold.

Friess Associates first reported a position in MEDP in Q3 2016 and held it in 2 quarters. The position peaked at $9.25M in Q4 2016. 77 funds tracked by Wall St. Rank hold MEDP as of Q1 2017.

  • Friess Associates reported no remaining Medpace position as of Q1 2017 after selling out during the quarter.
  • Friess Associates sold 256,326 Medpace shares in Q1 2017, an estimated $9.25M.
  • Friess Associates first reported a position in Medpace in Q3 2016 and held it in 2 quarters.
  • Friess Associates's Medpace position peaked at $9.25M in Q4 2016.
  • 77 funds tracked by Wall St. Rank held Medpace as of Q1 2017.

Based on Friess Associates's 13F filing for Q1 2017, filed 15 May 2017.